William Blair Weighs in on Encompass Health Co.’s Q1 2025 Earnings (NYSE:EHC)

Encompass Health Co. (NYSE:EHC) – Investment analysts at William Blair boosted their Q1 2025 earnings estimates for Encompass Health in a research note issued on Wednesday, April 24th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $1.30 for the quarter, up from their prior estimate of $1.03. William Blair has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.10 per share.

EHC has been the subject of a number of other research reports. Barclays increased their price target on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a research note on Thursday. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 price target on shares of Encompass Health in a research note on Friday, February 9th. Mizuho increased their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday. Stephens reiterated an “overweight” rating and issued a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Finally, Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Encompass Health presently has an average rating of “Buy” and a consensus target price of $88.13.

Encompass Health Stock Down 0.3 %

Encompass Health stock opened at $82.47 on Monday. The company has a market cap of $8.26 billion, a P/E ratio of 22.29, a price-to-earnings-growth ratio of 1.50 and a beta of 0.94. The company has a current ratio of 1.37, a quick ratio of 1.28 and a debt-to-equity ratio of 1.14. The company has a fifty day simple moving average of $78.25 and a 200 day simple moving average of $70.96. Encompass Health has a 1-year low of $57.55 and a 1-year high of $85.84.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.88 earnings per share.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is 16.22%.

Institutional Trading of Encompass Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. International Assets Investment Management LLC acquired a new stake in Encompass Health in the 4th quarter worth about $20,210,000. Sumitomo Mitsui Trust Holdings Inc. raised its stake in Encompass Health by 2.3% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock worth $87,989,000 after purchasing an additional 29,926 shares in the last quarter. Phocas Financial Corp. raised its stake in Encompass Health by 112.4% in the 4th quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock worth $6,664,000 after purchasing an additional 52,847 shares in the last quarter. Nordea Investment Management AB raised its stake in Encompass Health by 21.0% in the 4th quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock worth $6,787,000 after purchasing an additional 17,684 shares in the last quarter. Finally, Oak Thistle LLC increased its holdings in Encompass Health by 19.1% in the 4th quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock valued at $963,000 after buying an additional 2,319 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.